Hypereosinophilia Syndrome (HES)
1 clinical trials · Condition
◉ Watch Hypereosinophilia Syndrome (HES)
| Record | Firm | Date |
|---|---|---|
| A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases (NCT06512883) | AstraZeneca | 2025-04-17 |
Track Hypereosinophilia Syndrome (HES) automatically
Every clearance here is in the API, with alerts when new ones post.